Massachusetts challenges Gilead's hepatitis C drug prices 27.01.2016 20:25 Reuters (Reuters) - Massachusetts' attorney general is studying whether prices of Gilead Sciences Inc's blockbuster treatments for hepatitis C violate state law, according to a letter the prosecutor sent to the California drugmaker.
